Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
CRISPR-RNAa: targeted activation of translation using dCas13 fusions to translation initiation factors.
Otoupal PB, Cress BF, Doudna JA, Schoeniger JS
Nucleic Acids Res. 2022 Aug 11. pii: 6660959. doi: 10.1093/nar/gkac680.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
182711pPBO.ACT001aTc inducible dCasRx
182712pPBO.ACT002aTc inducible dCasRx-IF1
182713pPBO.ACT003aTc inducible dCasRx-IF3
182714pPBO.ACT004Constituitvely expressed CasRx crRNA cloning vector, extended 3' terminator region
182715pPBO.ACT005Constituitvely expressed CasRx crRNA cloning vector, truncated 3' terminator region
182716pPBO.ACT006Constituitvely expressed CasRx crRNA cloning vector, truncated 3' terminator region, with eGFP for cloning

Antibodies from Article